Navigation Links
Penicillin, amoxicillin: Step aside for strep throat treatment

Doctors today presented more evidence that it's time for long-time antibiotic stalwarts like penicillin and amoxicillin to step aside when it comes to the treatment of strep throat.

The most common medications used to treat the strep germ, the bug that causes millions of sore throats in U.S. children every year, simply aren't doing the job and aren't as effective as newer antibiotics known as cephalosporins. In results presented today at a large infectious disease meeting, the annual Interscience Conference on Antimicrobial Agents and Chemotherapy in Washington, doctors who reviewed the treatment given to 11,426 children showed that even a short course of the newer drugs is more effective than the traditional 10-day dose of the older antibiotics.

Pediatricians at the University of Rochester Medical Center found that 25 percent of children treated for strep throat with penicillin ended up back in the doctor's office within three weeks of treatment. Children treated with amoxicillin returned 18 percent of the time. The numbers were 14 percent for older-generation cephalosporins, and just 7 percent for newer ones like cefpodoxime and cefdinir, which are given for just four or five days.

The new results buttress previous work by physicians Michael Pichichero, M.D., and Janet Casey, M.D., showing that more children who receive the older drugs relapse, prolonging their illness and forcing doctors to turn to even stronger drugs. Yet, said Pichichero, doctors across the land continue to prescribe ineffective medications. Studies have shown that approximately 60 to 80 percent of children treated for strep are prescribed amoxicillin; 10 to 20 percent are prescribed penicillin; and just 10 to 20 percent receive a cephalosporin.

"Most doctors are shocked to learn of the high failure rates of the older medications," said Pichichero, a professor of Microbiology and Immunology.

"The treatment paradigm for treating strep sore throats has been
'"/>

Source:University of Rochester Medical Center


Page: 1 2 3

Related biology news :

1. Exercise aside, genes may ultimately dictate seniors mobility
2. Cloning the smell of the seaside
3. Children overprescribed antibiotics for sore throat
4. Protein discovery could unlock the secret to better TB treatment
5. Nanoparticles offer new hope for detection and treatment
6. Technique may allow cancer patients to freeze eggs, preserving fertility before starting treatment
7. PET/CT can identify new cancer lesions at early stage, allowing for prompt treatment
8. Newer imaging techniques may lead to over-treatment
9. Asymptomatic HIV babies could use earlier treatment
10. Enzymes newly discovered role may make it target for arthritis treatment
11. Identification of specific genes predicts which patients will respond to Hepatitis C treatment

Post Your Comments:
(Date:11/26/2009)... Ecologists have at last worked out a way of using...size of bird populations. This is the first time s...translated into accurate estimates of bird species... in the British Ecological Society,s Journal of A...t could lead to a major advance in our ability to ...
(Date:11/26/2009)..., Heidelberg, 27 November 2009 What are the ba...ts required to produce a cell that can survive on ...a cell, and understand how an entire organism func...tions that scientists in a partnership between the...eidelberg, Germany, and the Centre de Regulacio Ge...
(Date:11/25/2009)... Ghrelin, a hormone produced in the stomach, may b...pment of Parkinson,s disease, Yale School of Medic...ecent issue of the Journal of Neuroscience . , ... dopamine neurons in an area of the midbrain known... dopamine production. Reduced production of dopam...
Breaking Biology News(10 mins):Ecologists sound out new solution for monitoring cryptic species 2First-ever blueprint of a minimal cell is more complex than expected 2First-ever blueprint of a minimal cell is more complex than expected 3Hormone ghrelin can boost resistance to Parkinson's disease 2PharmaTelevision Turns the Media Spotlight Upon BIO Europe 14467 1PharmaTelevision Turns the Media Spotlight Upon BIO Europe 14467 2Sharp HealthCare Selects MEDais Pinpoint Review to Prevent Readmissions 5452 1Sharp HealthCare Selects MEDais Pinpoint Review to Prevent Readmissions 5452 2Sharp HealthCare Selects MEDais Pinpoint Review to Prevent Readmissions 5452 3Sharp HealthCare Selects MEDais Pinpoint Review to Prevent Readmissions 5452 4Record Revenue Growth for Medical Device Software Consulting Firm Full Spectrum Software 14465 1Record Revenue Growth for Medical Device Software Consulting Firm Full Spectrum Software 14465 2
...OneWorld Health, the first nonprofit pharmaceutica...ived Orphan Drug Designation from the two leading ...g Administration (FDA) and the European Agency for...paromomycin to treat visceral leishmaniasis (VL). ...a fatal disease transmitted by sand flies, which s...
...frican legal complaint against British drug maker ...nd policies in that country will proceed following...tion Tribunal that will allow the complaint to go ...case; however, the Competition Tribunal issued an ...thcare Foundation (AHF) and several South African ...
...ve discovered a specialized night-vision brain are...rea might enable the birds to navigate by the star...ld through photoreceptor molecules, whose light-se...hers published their findings May 23, 2005, in the...tional Academy of Sciences. The collaboration was ...
Other Biology News:OneWorld Health drug receives 'Orphan' designation from U.S. and European regulatory agencies 2South African Tribunal Asks For Damages Estimates in GSK AIDS Drug Case 2Migratory songbirds have a specialized night-vision brain area 2
(Date:11/25/2009)... Biotech firm Replikins Ltd., which...e 1918 pandemic through the prediction, outbreak, ...ssued its latest biochemical analysis of the virus...1 ("Swine Flu") virus has dropped from its peak of...k in the spring of 2009 to resting non-epidemic le...
(Date:11/25/2009)...PRNewswire/ - Cytochroma today announced the appoi...rs. Dr. Moldt will replace Mr. Ulrik Spork as the ...e number of Board members remains unchanged at six...ter Moldt to the board and look forward to benefit... continues to make progress in becoming a leading ...
(Date:11/25/2009)...RNewswire-FirstCall/ -- Ardea Biosciences, Inc. (N..., Pharm.D., president and chief executive officer,...lth Care Conference. , ,Presentation details are ... Conference,Date: Tuesday, December 1, 2009,T...w York Palace Hotel, New York, NY,Webcast: <a h...
(Date:11/24/2009)...or to also Visit Detroit , ...ia, French Ambassador for International Investment...ncy, , , , ,What: Ambassador Appia is available t...nitiatives adopted by France to further develop th...ovation and development., , ,When: Available for I...
Breaking Biology Technology:Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2
...hcare Facilities across North ...- Halogen Software Inc., the leading,provider of w...t software,today announced that strong fourth quar... lead as the solution of choice for the healthcare... a number of key accounts,this past quarter includ...
...Xinhua-PRNewswire-FirstCall/ --,Kiwa Bio-Tech Prod...reports,sharply improved volume of bio-fertilizer ...io-Tech Products (Shandong) Co., Ltd. ("Kiwa,Shand...ting in the,bio-fertilizer industry, sold 114 tons...r of 2007 as compared with 14 tons in the same per...
...more competition from private ...nture capitalists will largely,direct their invest...he,coming year, while China and India remain hot d...nt survey by the U.S. audit, tax and advisory,firm...talists, entrepreneurs, corporate,buyers, investme...
Other Biology Technology:Halogen Advances its Lead in Providing Employee Performance and Talent Management Solutions for the Healthcare Market 2Kiwa Bio-Tech Ships 114 Tons of Bio-Fertilizer in Fourth Quarter of 2007 2Venture Capitalists Bullish on Greentech and Biotech, KPMG Study Says 2Venture Capitalists Bullish on Greentech and Biotech, KPMG Study Says 3
Aedesta Animal Organ/Tissue Perfusion from Lifeblood Medical, Inc.
Rat Anti-Mouse JAM-2 Monoclonal Antibody, Unconjugated from AbD Serotec
Rabbit Anti-CSNK2A1 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
...ementary RNA Spikes for the normalization and cont... printing and for protocol assessment and optimiza...ling, hybridization stringency and background. Nor... Oligo Spots, and complementary RNA Spikes for the...
Biology Products: